Correction to: Gastric Cancer https://doi.org/10.1007/s10120-019-01010-1
We recently published the priming effect of a DNA demethylating agent in chemotherapy of gastric cancer (original article). Unfortunately, there are errors in the units of some panels in Fig. 2. The units for SN38 (the most upper three panels) and PTX (the second bottom two panels) should be “nM”, instead of “µM”.
The errors were produced when the unit for 5-FU (the two bottom panels) was corrected from “nM” to “µM” during the production stage. Accidentally, the units for SN38 and PTX were also changed. A correct Fig. 2 is shown below.
The publisher sincerely apologize for the error.
Effect of epigenetic priming by 5-aza-dC. Resistant cells were first treated with 5-aza-dC or mock first, and subsequently treated with a cytotoxic drug. The IC50 values were significantly lower for SN38 and CDDP, but not for PTX and 5-FU
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moro, H., Hattori, N., Nakamura, Y. et al. Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways. Gastric Cancer 23, 116–117 (2020). https://doi.org/10.1007/s10120-019-01013-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-019-01013-y